Cost-Effectiveness of Targeted Next-Generation Sequencing for Diagnosing Pre-XDR and XDR Tuberculosis in Rifampicin-Resistant Patients Across High-Burden Settings

Archivos de Bronconeumología · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles